Enhancing the QUAlity and Transparency Of health Research
A new report published on 17 September by the UK Science and Technology Committee asks the UK Government to enhance its effort to increase transparency of clinical trials.
The report focuses on different levels of trial transparency and provides recommendations for improving the current situation.
Full report is available here.
The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More